Fact CheckerSign in

NCT06227299Enrolling by invitation

INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma

INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register

Source: ClinicalTrials.gov · Last updated 14 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of this study is to create a large-scale register of all glaucoma patients diagnosed, followed and treated in a large tertiary centre specialising in glaucoma, in order to analyse whether specific factors influence the progression of the disease or guide our choice of treatment. This should lead to a better understanding of the disease and the factors to be taken into account when choosing the best treatment option for each patient, leading to safer, more effective and patient-centred care.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
5000 (estimated)
First submitted
17 Jan 2024
Start date
29 May 2018
Primary completion date
30 Aug 2018
Lead sponsor
Swiss Glaucoma Research Foundation
Diseases
Glaucoma
NCT number
NCT06227299

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 29 May 2018 to the primary completion date, 30 Aug 2018
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients who are unable to understand the implications of their inclusion in the study or who are unable or unwilling to give informed consent

Who the study is looking for

  • Diagnosis of glaucoma (open-angle, closed-angle, primary or secondary) or ocular hypertension (IOP \> 24 mmHg, medicated or not)
  • Patients who received treatment (medical, laser or surgical) at the Glaucoma Centre, Montchoisi Clinic and Swiss Visio Montchoisi
  • Age: 18 years old or older
  • Able and willing to provide informed written or verbal consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Swiss Visio Montchoisi
Coordinator of this site? Confirm its status
LausanneSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.